← All posts

Specialty Patients and Coverage Gaps: Where the Biggest 340B Losses Hide

Not all coverage losses are equal.

When a patient on lisinopril and metformin loses Medicaid, your FQHC loses a PPS encounter and maybe $50 per month in 340B savings on generic medications. It hurts, but it is manageable.

When a patient on antiretroviral therapy, a biologic for rheumatoid arthritis, or oral oncology loses Medicaid, you lose $15,000 to $40,000 per year in 340B program value — from a single patient.

That is the difference between a nuisance and a crisis. And most FQHCs treat every coverage lapse the same way: they wait for the claim to deny.

The Specialty Patient Math

Here is what one specialty patient is worth to your 340B program annually:

Therapy AreaTypical Annual Drug CostEstimated 340B Savings
HIV (ART regimen)$30,000 - $48,000$20,000 - $38,000
Hepatitis C (DAA)$24,000 - $90,000$18,000 - $70,000
Rheumatoid arthritis (biologic)$25,000 - $60,000$15,000 - $45,000
Diabetes (insulin + GLP-1)$8,000 - $20,000$5,000 - $15,000
Behavioral health (LAI antipsychotic)$15,000 - $30,000$10,000 - $22,000

Five HIV patients who lose coverage and do not get re-enrolled represent $100,000 to $190,000 in annual 340B savings — evaporated. Ten patients across multiple specialty categories and you are looking at half a million dollars.

Why Specialty Patients Are More Vulnerable

You might assume specialty patients are more engaged with their care and therefore more likely to maintain coverage. The opposite is often true:

  • Complex lives. Many specialty patients at FQHCs are dealing with poverty, housing instability, substance use, or mental health challenges alongside their primary condition. Paperwork gets lost.
  • Stigma avoidance. Some patients — particularly those with HIV — minimize contact with systems, including responding to Medicaid renewal notices.
  • Cognitive burden. Patients managing multiple medications and appointments have less bandwidth for administrative tasks like redetermination paperwork.
  • Work requirement confusion. Starting January 2027, many specialty patients will receive work requirement notices even though they likely qualify for the medically frail exemption. If nobody documents that exemption, they lose coverage by default.

The Coverage Monitoring Gap

Ask yourself three questions:

  1. Can you name every specialty patient on your panel whose Medicaid coverage is up for renewal in the next 90 days?
  2. Do you know which of those patients have documented medical frailty exemptions on file?
  3. Is anyone in your organization responsible for making sure those patients maintain coverage?

If you answered no to any of these, your highest-value patients are unprotected.

Building a Specialty Coverage Safety Net

Step 1: Identify Your High-Value Panel

Run a report of all patients on specialty medications filled through your 340B program. Cross-reference with Medicaid enrollment status. This is your priority list.

Step 2: Document Medical Frailty Now

Almost every specialty patient qualifies for the medically frail exemption under the OBBBA work requirements. Document it at the next visit — do not wait until January 2027. Every patient with HIV, active Hepatitis C treatment, autoimmune disease on biologics, or serious mental illness should have this on file.

Step 3: Monitor Coverage Proactively

Set up a system — even a spreadsheet — that tracks renewal dates for your top 50 specialty patients. When a renewal is 60 days out, trigger outreach. When it is 30 days out, escalate. This alone will prevent the majority of coverage lapses.

Step 4: Automate the Process

Manual tracking works for 50 patients. It does not scale to 500. CoverageGuard IQ automates the entire workflow — monitoring coverage status, scoring patients by clinical and financial risk, and generating a prioritized outreach queue. Specialty patients automatically surface at the top because their revenue exposure is highest.

See the prototype →

The Bottom Line

Generic coverage monitoring treats every patient the same. That is a mistake. Your specialty patients represent 80% of your 340B program value in 20% of your patient volume. Losing even a handful of them to preventable coverage gaps is a six-figure problem.

Protect your highest-value patients first. Everything else follows.